David Page

802 total citations
36 papers, 401 citations indexed

About

David Page is a scholar working on Hematology, Epidemiology and Infectious Diseases. According to data from OpenAlex, David Page has authored 36 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in David Page's work include Hemophilia Treatment and Research (27 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). David Page is often cited by papers focused on Hemophilia Treatment and Research (27 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). David Page collaborates with scholars based in Canada, United States and Ireland. David Page's co-authors include Mark W. Skinner, Brian O’Mahony, Declan Noone, Alfonso Iorio, Sumedha Arya, Jeffrey S. Stonebraker, Randall Curtis, Michael B. Nichol, Rochelle Winikoff and Michelle Sholzberg and has published in prestigious journals such as Blood, PLoS ONE and Molecular Therapy.

In The Last Decade

David Page

35 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Page Canada 12 288 44 42 35 26 36 401
Katharine Batt United States 15 314 1.1× 53 1.2× 44 1.0× 5 0.1× 40 1.5× 49 565
Sandra Ziegler Germany 9 75 0.3× 44 1.0× 37 0.9× 5 0.1× 34 1.3× 19 336
Marianna Cavazza Italy 10 74 0.3× 25 0.6× 39 0.9× 5 0.1× 14 0.5× 25 367
Marta Zapata‐Tarrés Mexico 11 44 0.2× 27 0.6× 42 1.0× 9 0.3× 9 0.3× 64 358
James H. Jackson United States 10 55 0.2× 36 0.8× 11 0.3× 6 0.2× 11 0.4× 33 252
Dražen Stojanović Croatia 8 39 0.1× 29 0.7× 28 0.7× 125 3.6× 7 0.3× 18 439
Eddy Supriyadi Indonesia 8 37 0.1× 12 0.3× 58 1.4× 17 0.5× 20 0.8× 21 344
Megan M. Ullman United States 9 331 1.1× 48 1.1× 30 0.7× 1 0.0× 17 0.7× 25 371
Nancy A. Omondi United States 7 140 0.5× 29 0.7× 9 0.2× 13 0.4× 2 0.1× 8 274
Christine Guelcher United States 11 311 1.1× 55 1.3× 43 1.0× 20 0.8× 31 380

Countries citing papers authored by David Page

Since Specialization
Citations

This map shows the geographic impact of David Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Page more than expected).

Fields of papers citing papers by David Page

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Page. The network helps show where David Page may publish in the future.

Co-authorship network of co-authors of David Page

This figure shows the co-authorship network connecting the top 25 collaborators of David Page. A scholar is included among the top collaborators of David Page based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Page. David Page is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curtis, Randall, Joanne Wu, Alfonso Iorio, et al.. (2024). Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study. Haemophilia. 30(3). 702–708. 1 indexed citations
2.
Kaczmarek, Radosław, Glenn F. Pierce, Declan Noone, et al.. (2023). Hemophilia gene therapy: first, do no harm. Journal of Thrombosis and Haemostasis. 21(9). 2354–2361. 11 indexed citations
3.
Shaw, Joseph R., Jonathan Douxfils, Yesim Dargaud, et al.. (2023). Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature. PLoS ONE. 18(11). e0293632–e0293632. 5 indexed citations
4.
Gopal, Srila, et al.. (2022). Patient‐derived assessment tool using musculoskeletal ultrasound for validation of haemarthrosis. Haemophilia. 28(5). 842–848. 3 indexed citations
5.
6.
Kaczmarek, Radosław, Magdy El Ekiaby, Daniel P. Hart, et al.. (2021). Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders. Haemophilia. 27(4). 515–518. 6 indexed citations
7.
Arya, Sumedha, et al.. (2021). Invisible bleeds: Lived experiences and barriers to care for men with hemophilia. Journal of Thrombosis and Haemostasis. 20(2). 296–306. 3 indexed citations
8.
Arya, Sumedha, David Page, Rochelle Winikoff, et al.. (2021). “They don’t really take my bleeds seriously”: Barriers to care for women with inherited bleeding disorders. Journal of Thrombosis and Haemostasis. 19(6). 1506–1514. 37 indexed citations
9.
Page, David, et al.. (2021). Vaccine‐induced immune thrombotic thrombocytopenia presenting with normal platelet count. Research and Practice in Thrombosis and Haemostasis. 5(6). e12596–e12596. 12 indexed citations
10.
Pierce, Glenn F., Radosław Kaczmarek, Declan Noone, et al.. (2020). Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?. Haemophilia. 26(6). 931–933. 19 indexed citations
11.
Arya, Sumedha, et al.. (2020). Healthcare provider perspectives on inequities in access to care for patients with inherited bleeding disorders. PLoS ONE. 15(2). e0229099–e0229099. 18 indexed citations
12.
Chai‐Adisaksopha, Chatree, Declan Noone, Randall Curtis, et al.. (2020). Non‐severe haemophilia: Is it benign? – Insights from the PROBE study. Haemophilia. 27(S1). 17–24. 25 indexed citations
13.
Arya, Sumedha, David Page, Rochelle Winikoff, et al.. (2020). “Everything was blood when it comes to me”: Understanding the lived experiences of women with inherited bleeding disorders. Journal of Thrombosis and Haemostasis. 18(12). 3211–3221. 31 indexed citations
14.
Page, David. (2019). Parent testimonial: A caregiver whose son with inhibitors has been receiving emicizumab. Transfusion and Apheresis Science. 58(5). 563–564. 1 indexed citations
15.
Chai‐Adisaksopha, Chatree, Mark W. Skinner, Randall Curtis, et al.. (2018). Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire. BMJ Open. 8(8). e021900–e021900. 19 indexed citations
16.
Skinner, Mark W., Chatree Chai‐Adisaksopha, Randall Curtis, et al.. (2018). The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia. Pilot and Feasibility Studies. 4(1). 58–58. 36 indexed citations
17.
Skinner, Mark W., Chatree Chai‐Adisaksopha, Randall Curtis, et al.. (2017). Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study. Blood. 130. 3411–3411. 1 indexed citations
18.
Page, David, et al.. (2008). Integrated specialty service readiness in health reform: connections in haemophilia comprehensive care. Haemophilia. 14(3). 436–443. 2 indexed citations
19.
McCullough, Jeffrey, Jean‐Pierre Bouchard, Dean Fergusson, et al.. (2004). Consensus conference on vCJD screening of blood donors: report of the panel. Transfusion. 44(5). 675–683. 13 indexed citations
20.
Page, David, et al.. (2002). Factors influencing immunization status in primary care clinics.. PubMed. 34(1). 29–33. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharine Batt Breakdown of academic impact, for papers by Sandra Ziegler Breakdown of academic impact, for papers by Marianna Cavazza Breakdown of academic impact, for papers by Marta Zapata‐Tarrés Breakdown of academic impact, for papers by James H. Jackson Breakdown of academic impact, for papers by Dražen Stojanović Breakdown of academic impact, for papers by Eddy Supriyadi Breakdown of academic impact, for papers by Megan M. Ullman Breakdown of academic impact, for papers by Nancy A. Omondi Breakdown of academic impact, for papers by Christine Guelcher
Rankless by CCL
2026